SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques

Ramon Roozendaal, Laura Solforosi, Daniel J. Stieh, Jan Serroyen, Roel Straetemans, Anna Dari, Muriel Boulton, Frank Wegmann, Sietske K. Rosendahl Huber, Joan E. M. van der Lubbe, Jenny Hendriks, Mathieu Le Gars, Liesbeth Dekking, Dominika N. Czapska-Casey, Nuria Guimera, Sarah Janssen, Sarah Tete, Abishek Chandrashekar, Noe B. Mercado, Jingyou Yu, Wouter Koudstaal, Juan J. Perez-Ruixo, Jerry Sadoff, Dan H. Barouch, Hanneke Schuitemaker and Roland Zahn ()
Additional contact information
Ramon Roozendaal: Janssen Vaccines & Prevention B.V.
Laura Solforosi: Janssen Vaccines & Prevention B.V.
Daniel J. Stieh: Janssen Vaccines & Prevention B.V.
Jan Serroyen: Janssen Vaccines & Prevention B.V.
Roel Straetemans: Janssen R&D
Anna Dari: Janssen R&D
Muriel Boulton: Janssen R&D
Frank Wegmann: Janssen Vaccines & Prevention B.V.
Sietske K. Rosendahl Huber: Janssen Vaccines & Prevention B.V.
Joan E. M. van der Lubbe: Janssen Vaccines & Prevention B.V.
Jenny Hendriks: Janssen Vaccines & Prevention B.V.
Mathieu Le Gars: Janssen Vaccines & Prevention B.V.
Liesbeth Dekking: Janssen Vaccines & Prevention B.V.
Dominika N. Czapska-Casey: Janssen Vaccines & Prevention B.V.
Nuria Guimera: Janssen Vaccines & Prevention B.V.
Sarah Janssen: Janssen Vaccines & Prevention B.V.
Sarah Tete: Janssen Vaccines & Prevention B.V.
Abishek Chandrashekar: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Noe B. Mercado: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Jingyou Yu: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Wouter Koudstaal: Lucidity Biomedical Consulting
Juan J. Perez-Ruixo: Janssen R&D
Jerry Sadoff: Janssen Vaccines & Prevention B.V.
Dan H. Barouch: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Hanneke Schuitemaker: Janssen Vaccines & Prevention B.V.
Roland Zahn: Janssen Vaccines & Prevention B.V.

Nature Communications, 2021, vol. 12, issue 1, 1-10

Abstract: Abstract Several COVID-19 vaccines have recently gained authorization for emergency use. Limited knowledge on duration of immunity and efficacy of these vaccines is currently available. Data on other coronaviruses after natural infection suggest that immunity to SARS-CoV-2 might be short-lived, and preliminary evidence indicates waning antibody titers following SARS-CoV-2 infection. In this work, we model the relationship between immunogenicity and protective efficacy of a series of Ad26 vectors encoding stabilized variants of the SARS-CoV-2 Spike protein in rhesus macaques and validate the analyses by challenging macaques 6 months after immunization with the Ad26.COV2.S vaccine candidate that has been selected for clinical development. We show that Ad26.COV2.S confers durable protection against replication of SARS-CoV-2 in the lungs that is predicted by the levels of Spike-binding and neutralizing antibodies, indicating that Ad26.COV2.S could confer durable protection in humans and immunological correlates of protection may enable the prediction of durability of protection.

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-021-26117-x Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-26117-x

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-021-26117-x

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().